全球體外肺模型市場按類型、應用、最終用戶和地區分類

Global In Vitro Lung Model Market, By Type, By Application, By End User, By Geography

出版日期: 2025年03月04日 | 出版商:

Coherent Market Insights | 英文 176 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2025 年全球離體肺模型市場價值估計為 3.38 億美元，預計到 2032 年將達到 8.666 億美元，2025 年至 2032 年的複合年成長率為 14.4%。

報告範圍		報告詳細資訊
基準年	2024	2025年的市場規模	3.38億美元
效能數據	從2020年到2024年	預測期	2025年至2032年
預測期：2025-2032年複合年成長率：	14.40%	2032年價值預測	8.666億美元

數字。 2025年全球市場佔有率（%）

體外肺模型是一種旨在模擬人類肺部的生理和解剖特性的實驗系統。它廣泛應用於藥物研發、毒性測試和肺部疾病研究。透過利用體外培養的人類肺細胞和組織，這些模型提供了一種比動物試驗相對便宜且有效的替代方法。與動物模型相比，它們也為研究人類肺部生物學和疾病病理學提供了更真實、更可控的環境。未來，組織工程、微流體和其他技術的進步有望幫助開發高度複雜的 3D 肺模型，以更好地重現體內肺微環境。

市場動態：

全球體外肺模型市場受到製藥公司對藥物研發的投資增加、動物試驗的嚴格規定以及呼吸系統疾病盛行率增加等因素的推動。然而，開發先進的 3D 肺模型的高成本和較短的組織保存期限預計會抑制市場成長。同時，微製造和3D生物列印技術的不斷發展有望為開發下一代仿生模型提供重大機會。此外，隨著人們的注意力集中在開發包含個別患者細胞和組織的個人化肺模型上，市場預計還會擴大。

然而，預計市場參與企業加強研發力度將在預測期內進一步推動市場成長。例如，2024年3月6日，生物技術公司AlveoliX AG在Frontiers Media SA上發表了一項研究，題為“一種連接複用吸入平台，用於模擬慢性阻塞性肺病”，因為美國食品藥物管理局（FDA）針對各種呼吸系統疾病（包括氣喘、慢性阻塞性肺病（COPD）和纖維化）開發的藥物數量。由於美國食品藥物管理局(FDA)核准治療這些嚴重肺部疾病的吸入藥物數量有限，臨床前研究已從體內研究轉向使用替代的離體人體相關模型，以更準確地預測吸入顆粒的毒性。

本研究的主要特點

本研究報告對全球試管內肺模型市場進行了詳細分析，並給出了預測期（2025-2032）的市場規模和年複合成長率（CAGR%），假設 2024 年為基準年。
它還揭示了各個領域的潛在商機，並說明了該市場的引人注目的投資提案矩陣。
它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的重要見解。
它根據公司亮點、產品系列、關鍵亮點、績效和策略等參數，介紹了全球體外肺模型市場的主要企業概況。
本報告的見解將使負責人和公司經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
全球體外肺模型市場報告針對該行業的各個相關人員，包括投資者、供應商、產品製造商、經銷商、新進入者和金融分析師。
相關人員將透過用於分析全球體外肺模型市場的各種策略矩陣來做出決策。

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	USD 338.0 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	14.40%	2032 Value Projection:	USD 866.6 Mn

In vitro lung models are experimental systems that aim to mimic the physiological and anatomical properties of the human lungs. They are widely used in drug discovery, toxicity testing, and studying lung diseases. By utilizing human lung cells and tissues grown outside of the body, these models offer a relatively affordable and effective alternative to animal testing. They also provide a more realistic and controllable environment to study human lung biology and disease pathology compared to animal models. Going forward, advances in tissue engineering, microfluidics, and other technologies are expected to help develop highly complex 3D lung models that can better recreate the in vivo lung microenvironment.

Market Dynamics:

The global in vitro lung model market is driven by factors such as rising drug R&D investments by pharmaceutical companies, stringent regulations regarding animal testing, and increasing prevalence of respiratory diseases. However, high costs associated with developing advanced 3D lung models and shorter shelf life of tissues are expected to restrain the market growth. Meanwhile, ongoing advances in microfabrication and 3D bioprinting technologies are projected to create significant opportunities for manufacturers to develop next-gen biomimetic models. The market is also anticipated to gain from growing focus on developing personalized lung models incorporating individual patient-derived cells and tissues.

On the other hand, rising research and development by market players is further expected to propel the market growth over the forecast period. For instance, on March 6, 2024, AlveoliX AG, a biotechnology company, published a study in Frontiers Media S.A., a peer-reviewed, open access, scientific journals, entitled "A multiplex inhalation platform to model in situ like aerosol delivery in a breathing lung-on-chip" for various respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD) and fibrosis, due to limited number of U.S. Food and Drug Administration, approved inhaled drugs for these serious lung conditions has led to a shift from in vivo towards the use of alternative in vitro human-relevant models to better predict the toxicity of inhaled particles in preclinical research.

Key features of the study:

This report provides an in-depth analysis of the global In vitro lung model market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global In vitro lung model market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Histogen Inc., OliX Pharmaceuticals, Cipla Limited, Aclaris Therapeutics, Inc., Merck & Co., Inc., Daiichi-Sankyo Co., Ltd., Johnson and Johnson Services, Inc., Lexington International LLC, Vita-Cos-Med Klett-Loch GmbH, PureTech, Vitabiotics, Dr. Reddy's Laboratories, HCell Inc., Follica, Inc. and Ranbaxy Laboratories Ltd.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global In vitro lung model market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global In vitro lung model market

Detailed Segmentation:

Global In Vitro Lung Model Market, By Type
- 2D Model
- 3D Model
Global In Vitro Lung Model Market, By Application
- Drug Discovery & Toxicology Studies
- Physiological Research
- 3D Model Development
- Others
Global In Vitro Lung Model Market, By End User
- Academic and Research Institutes
- Biopharmaceutical Companies
- Others
Global In Vitro Lung Model Market, By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Company Profiles
- Histogen Inc.
- OliX Pharmaceuticals
- Cipla Limited
- Aclaris Therapeutics, Inc.
- Merck & Co., Inc.
- Daiichi-Sankyo Co., Ltd.
- Johnson and Johnson Services, Inc.
- Lexington International LLC
- Vita-Cos-Med Klett-Loch GmbH
- PureTech
- Vitabiotics
- Dr. Reddy's Laboratories
- HCell Inc.
- Follica, Inc.
- Ranbaxy Laboratories Ltd.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global In Vitro Lung Model Market, By Type
- Global In Vitro Lung Model Market, By Application
- Global In Vitro Lung Model Market, By End User
- Global In Vitro Lung Model Market, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Rising prevalence of lung diseases
- High costs associated with animal models
- Growing preference for 3D lung models over 2D models
Impact Analysis
Key Highlights
Regulatory Scenario
Service offering Portfolio
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Global In Vitro Lung Model Market- Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Global In Vitro Lung Model Market, By Type, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
2D Model
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
3D Model
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)

6. Global In Vitro Lung Model Market, By Application, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Drug Discovery & Toxicology Studies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
Physiological Research
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
3D Model Development
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)

7. Global In Vitro Lung Model Market, By End User, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Academic and Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
Biopharmaceutical Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)

8. Global In Vitro Lung Model Market, By Region, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, By Country, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Country 2021 -2032
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Mn)
  - U.S.
  - Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Mn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Mn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Mn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Mn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032, (US$ Mn)
  - North Africa
  - Central Africa
  - South Africa

9. Competitive Landscape

Epithelix
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
MATTEK
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Lonza
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Emulate
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
AlveoliX AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Nortis
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Strategies
CN Bio Innovations Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
MIMETAS
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
InSphero
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
ATTC Global
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Tissuse GmbH
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Cn Bio Innovations Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Analyst Views